Press Release Service: Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2 Years and Older With Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia
Press Release Service: Vertex Announces US FDA Approval for Expanded Use of CASGEVY® for the Treatment of People Ages 2…